Molecular docking of an antianxiety drug molecule "3-[2-(1H-Benzimidazol-2-ylsulfan-yl) eth-yl]-1, 3-oxazolidin-2-one"

Abdellatif Bouayyadi, Aissam El Aliani, Yassine Kasmi, Ahmed Moussaif, Abdelhalim Mesfioui, El Mokhtar Essassi, Mohammed El Mzibri. Molecular docking of an antianxiety drug molecule "3-[2-(1H-Benzimidazol-2-ylsulfan-yl) eth-yl]-1, 3-oxazolidin-2-one". I. J. Computational Biology and Drug Design, 15(1):30-42, 2022. [doi]

Abstract

Abstract is missing.